GlassScriptPhysician profile
Emilie Fleagle
NPI 1396463402
$2,494.41
in general payments reported to CMS, 2019-2025
15 companies · $1,587 in 2025
The $1,587 reported for 2025 was more than what 89% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $130 · 2024: $777 · 2025: $1,587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,482 · Education: $12.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,481.75 |
| Education | $12.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.15 | 2024-2025 | |
| Neurocrine Biosciences, INC. | $325.46 | 2024-2025 | Ingrezza |
| Takeda Pharmaceuticals U.S.A., INC. | $260.90 | 2024-2025 | Trintellix |
| Lundbeck LLC | $251.84 | 2025 | Rexulti |
| Alkermes, INC. | $238.60 | 2025 | Aristada, Lybalvi |
| E.R. Squibb & Sons, L.L.C. | $215.37 | 2024-2025 | Cobenfy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $162.77 | 2025 | Caplyta |
| Collegium Pharmaceutical, INC. | $157.74 | 2025 | Jornay Pm |
| Jazz Pharmaceuticals INC. | $138.84 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $130.00 | 2023 | |
| Corium, LLC | $121.62 | 2024-2025 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $80.74 | 2025 | Rexulti |
| Ironshore Pharmaceuticals INC. | $38.64 | 2024 | |
| Janssen Pharmaceuticals, INC | $24.22 | 2025 | Invega Trinza, Invega Sustenna |
| Neos Therapeutics, LP | $14.52 | 2025 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emilie Fleagle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.